Journal of Refractive Surgery
Online Advanced Release
Current Issue
Back Issues
About the Journal
Info for Authors
Contributor Awards
Article Submission
Contact Us
Advertising Info
Article Reprints
Buy a Book
Terms and Conditions
Careers at SLACK Inc.

e-contents - Sign up today
Subscribe to this Journal
Get daily Ophthalmic news at the OSN SuperSite
ISRS: International Society of Refractive Surgery

Faktorovich, Femtodynamics

Original Articles:
Corneal Limbal Marking in the Treatment of Myopic Astigmatism With the Excimer Laser

Journal of Refractive Surgery  Vol. 26   No. 7   July 2010

See the Full text
Celine Bucher; Bruno Zuberbuhler, MD; Michael Goggin, FRCSI(Ophth); Adrian Esterman, AStat, PhD and Isaak Schipper, MD

Share/Save/Bookmark

 

PURPOSE

To determine whether preoperative marking of the limbal cornea improves treatment of myopic astigmatism with the excimer laser.

METHODS

Retrospective study on 108 eyes with myopic astigmatism that underwent LASIK or laser epithelial keratomileusis (LASEK) with the Technolas 217 (Bausch & Lomb) excimer laser. Preoperative limbal marking was performed in 47 eyes (marked group). The 12-month results were used for refractive and visual analysis.

RESULTS

The achieved cylinder reduction, spherical reduction, and refractive predictability were similar for the marked and unmarked groups in the overall study collective, in the LASIK and LASEK subgroup analysis, and in a higher astigmatism (>1.25 diopters) subgroup analysis. Limbal marking showed no influence on the refractive results, and vector analysis showed no significant difference in angle of error among groups.

CONCLUSIONS

Corneal limbal marking failed to improve the refractive outcome in LASIK and LASEK for myopic astigmatism. [J Refract Surg. 2010;26(7):505-511.]

AUTHORS

From Augenklinik, Kantonsspital, Lucerne, Switzerland (Bucher, Schipper); Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom (Zuberbuhler); South Australian Institute of Ophthalmology, University of Adelaide, Australia (Goggin); and School of Nursing and Midwifery, University of South Australia, Adelaide, Australia (Esterman).

Dr Zuberbuhler is on the advisory board of Zubisoft Corp. The remaining authors have no financial or proprietary interest in the materials presented herein.

Correspondence: Isaak Schipper, MD, Augenklinik, Kantonsspital, CH-6000 Lucerne 16, Switzerland. Tel: 41 412 051 111; Fax: 41 412 053 406; E-mail: isaak.schipper@ksl.ch

Received: October 8, 2008; Accepted: July 23, 2009

Posted online: August 17, 2009

doi:10.3928/1081597X-20090814-01

See the Full text